Entity Details

Primary name GJC2
Entity type gene
Source Source Link

Details

PrimaryID57165
RefseqGeneNG_011838
SymbolGJC2
Namegap junction protein gamma 2
Chromosome1
Location1q42.13
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2000-09-12
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsCXG2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001932 regulation of protein phosphorylation
GO:0005243 gap junction channel activity
GO:0005921 gap junction
GO:0005922 connexin complex
GO:0007267 cell-cell signaling
GO:0007420 brain development
GO:0009636 response to toxic substance
GO:0010628 positive regulation of gene expression
GO:0010644 cell communication by electrical coupling
GO:0016021 integral component of membrane
GO:0033270 paranode region of axon
GO:0043204 perikaryon
GO:0043209 myelin sheath
GO:0070447 positive regulation of oligodendrocyte progenitor proliferation
GO:1903763 gap junction channel activity involved in cell communication by electrical coupling
GO:1904427 positive regulation of calcium ion transmembrane transport
GO:1990769 proximal neuron projection
GO:2000134 negative regulation of G1/S transition of mitotic cell cycle

Diseases

Show/Hide Table
Disease IDSourceNameDescription
608804 OMIMLeukodystrophy, hypomyelinating, 2 (HLD2)An autosomal recessive hypomyelinating leukodystrophy with symptoms of Pelizaeus-Merzbacher disease. Clinically characterized by nystagmus, impaired motor development, ataxia, choreoathetotic movements, dysarthria, and progressive spasticity. The disease is caused by variants affecting the gene represented in this entry.
613206 OMIMSpastic paraplegia 44, autosomal recessive (SPG44)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. The disease is caused by variants affecting the gene represented in this entry.
613480 OMIMLymphatic malformation 3 (LMPHM3)A form of primary lymphedema, a disease characterized by swelling of body parts due to developmental anomalies and functional defects of the lymphatic system. Patients with lymphedema may suffer from recurrent local infections. LMPHM3 is an autosomal dominant form with variable severity and reduced penetrance. Affected individuals manifest lymphedema of the lower limbs and some patients have lymphedema of the hands. The disease is caused by variants affecting the gene represented in this entry.

Interactions

7 interactions

InteractorPartnerSourcesPublicationsLink
GJC2ADRB2BioGRID, MINT28298427 details
GJC2F2RL1BioGRID, MINT28298427 details
GJC2GPR35BioGRID, MINT28298427 details
GJC2LTB4R2BioGRID, MINT28298427 details
GJC2CHRM2BioGRID, MINT28298427 details
GJC2PTGER4BioGRID, MINT28298427 details
GJC2ALBBioGRID, IntAct15174051 details